Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
China Pharma HoldingSTU:XQJ 29 Equity-to-Asset is 0.81 as of Jun. 2026, which is 62% above its 10-year median of 0.50. GuruFocus rates STU:XQJ with a GF Score™ of 29/100 and a GF Value™ of €5.99. The stock has 4 warning signs investors should review. Among 1,007 Drug Manufacturers companies, China Pharma Holding ranks better than 82.03% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. China Pharma Holding's Total Stockholders Equity for the quarter that ended in Jun. 2026 was €31.41 Mil. China Pharma Holding's Total Assets for the quarter that ended in Jun. 2026 was €38.81 Mil.
Therefore, China Pharma Holding's Equity to Asset Ratio for the quarter that ended in Jun. 2026 was 0.81.
The historical rank and industry rank for China Pharma Holding's Equity-to-Asset or its related term are showing as below:
STU:XQJ'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.18 Med: 0.5 Max: 0.82
Current: 0.81
During the past 13 years, the highest Equity to Asset Ratio of China Pharma Holding was 0.82. The lowest was 0.18. And the median was 0.50.
STU:XQJ's Equity-to-Asset is ranked better than 82.03% of 1007
companies
in the Drug Manufacturers industry
Industry Median: 0.6
vs STU:XQJ: 0.81
China Pharma Holding (STU:XQJ) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
China Pharma Holding Equity-to-Asset Related Terms
China Pharma Holding Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for China Pharma Holding's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:XQJ vs IXHL, MRMD, RMTI: Equity-to-Asset Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, China Pharma Holding's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Pharma Holding Equity-to-Asset vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, China Pharma Holding's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where China Pharma Holding's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
China Pharma Holding's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Pharma Holding (STU:XQJ) has a Equity-to-Asset of 0.81 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on China Pharma Holding and its competitors. This is 62% above median its historical median of 0.50. Over the past decade, China Pharma Holding's Equity-to-Asset has ranged from 0.18 to 0.82. According to the industry distribution chart, China Pharma Holding ranks #181 out of 1007 companies in the Drug Manufacturers industry, placing it in the top 18%.
Is China Pharma Holding's Equity-to-Asset too high?
China Pharma Holding's current Equity-to-Asset of 0.81 is 62% above median its 10-year median of 0.50. Over the past 10 years, this metric has ranged from a low of 0.18 to a high of 0.82. The Drug Manufacturers industry median Equity-to-Asset is 0.60. China Pharma Holding's value of 0.81 is 35% above this industry median. Based on the distribution chart, China Pharma Holding ranks #181 out of 1007 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, China Pharma Holding has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does China Pharma Holding's Equity-to-Asset compare to IXHL and MRMD?
According to the Drug Manufacturers industry distribution chart, China Pharma Holding ranks #181 out of 1007 companies for Equity-to-Asset. This places China Pharma Holding in the top 18% of its industry — outperforming the majority of peers. The industry median Equity-to-Asset is 0.60. China Pharma Holding's value of 0.81 is 35% above this benchmark. Historically, China Pharma Holding's own Equity-to-Asset has ranged from 0.18 to 0.82 over the past decade. While the company's 10-year median is 0.50 vs. the industry median of 0.60, China Pharma Holding has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Drug Manufacturers company?
The median Equity-to-Asset among Drug Manufacturers companies is 0.60, based on 1,007 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Pharma Holding's current Equity-to-Asset of 0.81 is 35% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on China Pharma Holding and its competitors. For the Drug Manufacturers industry, the median Equity-to-Asset is 0.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Pharma Holding's current Equity-to-Asset is 0.81, which is 62% above median its own 10-year median of 0.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Pharma Holding stock overvalued right now?
China Pharma Holding (STU:XQJ) has a current Equity-to-Asset of 0.81. The stock's GF Value™ is €5.99, compared to a current price of €26.80 — trading 347.4% above its estimated fair value. The current Equity-to-Asset is 0.81, which is 62% above median its 10-year median of 0.50 and 35% above the Drug Manufacturers industry median of 0.60. China Pharma Holding's overall GF Score™ is 29/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For China Pharma Holding (STU:XQJ), the current Equity-to-Asset is 0.81 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Pharma Holding (STU:XQJ) Overvalued in 2026?
Based on GuruFocus' analysis, China Pharma Holding stock appears to be overvalued.
The current stock price of €26.80 is trading 347.4% above its estimated GF Value™ of €5.99.
Key valuation signals for STU:XQJ:
Equity-to-Asset: 0.81 (62% above median its 10-year median of 0.50)
GF Value™: €5.99 vs. price of €26.80 (347.4% above fair value)
Industry Position: 35% above the Drug Manufacturers median (#181 of 1007)
No single metric tells the full story. See the STU:XQJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.
29GF Score
Get the complete analysis for STU:XQJ
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:XQJ has been successfully added to your 
